1. Home
  2. COCO vs TLX Comparison

COCO vs TLX Comparison

Compare COCO & TLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo The Vita Coco Company Inc.

COCO

The Vita Coco Company Inc.

HOLD

Current Price

$53.69

Market Cap

3.1B

ML Signal

HOLD

Logo Telix Pharmaceuticals Limited American Depositary Shares

TLX

Telix Pharmaceuticals Limited American Depositary Shares

HOLD

Current Price

$7.75

Market Cap

3.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
COCO
TLX
Founded
2004
2015
Country
United States
Australia
Employees
N/A
N/A
Industry
Beverages (Production/Distribution)
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.1B
3.3B
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
COCO
TLX
Price
$53.69
$7.75
Analyst Decision
Buy
Strong Buy
Analyst Count
9
4
Target Price
$55.13
$21.00
AVG Volume (30 Days)
623.0K
193.1K
Earning Date
10-29-2025
01-15-2026
Dividend Yield
N/A
N/A
EPS Growth
15.16
N/A
EPS
1.15
0.04
Revenue
$609,286,000.00
$664,225,558.00
Revenue This Year
$18.22
N/A
Revenue Next Year
$13.69
N/A
P/E Ratio
$46.37
$181.75
Revenue Growth
23.12
55.35
52 Week Low
$25.79
$7.72
52 Week High
$55.29
$30.36

Technical Indicators

Market Signals
Indicator
COCO
TLX
Relative Strength Index (RSI) 58.27 30.67
Support Level $52.87 $7.72
Resistance Level $54.89 $8.22
Average True Range (ATR) 1.33 0.25
MACD -0.36 -0.06
Stochastic Oscillator 61.66 1.31

Price Performance

Historical Comparison
COCO
TLX

About COCO The Vita Coco Company Inc.

The Vita Coco Co Inc is a plant-based functional hydration platform. Its products include Vita Coco Coconut Water, Private Label including coconut water and oil, and Other including Runa, Ever & Ever, and PWR LIFT product offerings, Vita Coco product extensions beyond coconut water, such as Vita Coco Sparkling, coconut milk products, and others. The company has two segments: The Americas segment which comprises of operations in the U.S. and Canada; and The International segment that comprises of operations in Europe, the Middle East, Africa and the Asia Pacific regions. The Americas segment derives maximum revenue. Geographical presence of the company is in United States, United Kingdom and All other countries.

About TLX Telix Pharmaceuticals Limited American Depositary Shares

Telix develops radiopharmaceuticals to manage cancer. Radiopharmaceuticals are radioisotopes bound to molecules that can target specific cells. At low doses, these drugs can bind to specific cancer cells with radiation, and then positron emission tomography imaging can accurately visualize tumors. At high doses, these drugs can selectively target and treat tumors with radiation, known as radioligand therapy. Radiopharmaceuticals are usually injected into the bloodstream. Telix has a pipeline of potential radiopharmaceuticals but currently earns most of its revenue from US sales of Illuccix, largely used as an imaging agent to visualize the spread of prostate cancer.

Share on Social Networks: